• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (36)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Women's Health  • Women's Health, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Richard L. Prince, MD; Nicole Austin, BSc; Amanda Devine, PhD; Ian M. Dick, PhD; David Bruce, MD; Kun Zhu, PhD

Arch Intern Med. 2008;168(1):103-108.

Background  Ergocalciferol (vitamin D₂) supplementation plays a role in fall prevention, but the effect in patients living in the community in sunny climates remains uncertain. We evaluated the effect of ergocalciferol and calcium citrate supplementation compared with calcium alone on the risk of falls in older women at high risk of falling.

Methods  A 1-year population-based, double-blind, randomized controlled trial of 302 community-dwelling ambulant older women aged 70 to 90 years living in Perth, Australia (latitude, 32°S), with a serum 25-hydroxyvitamin D concentration of less than 24.0 ng/mL and a history of falling in the previous year. Participants were randomized to receive ergocalciferol, 1000 IU/d, or identical placebo (hereinafter, ergocalciferol and control groups, respectively). Both groups received calcium citrate, 1000 mg/d. Fall data were collected every 6 weeks.

Results  Ergocalciferol therapy reduced the risk of having at least 1 fall over 1 year after adjustment for baseline height, which was significantly different between the 2 groups (ergocalciferol group, 53.0%; control group, 62.9%; odds ratio [OR], 0.61; 95% confidence interval [CI], 0.37-0.99). When those who fell were grouped by the season of first fall or the number of falls they had, ergocalciferol treatment reduced the risk of having the first fall in winter and spring (ergocalciferol group, 25.2%; control group, 35.8%; OR, 0.55; 95% CI, 0.32-0.96) but not in summer and autumn, and reduced the risk of having 1 fall (ergocalciferol group, 21.2%; control group, 33.8%; OR, 0.50; 95% CI, 0.28-0.88) but not multiple falls.

Conclusion  Patients with a history of falling and vitamin D insufficiency living in sunny climates benefit from ergocalciferol supplementation in addition to calcium, which is associated with a 19% reduction in the relative risk of falling, mostly in winter.

Trial Registration  actr.org.au Identifier: 12606000331538

Author Affiliations: School of Medicine and Pharmacology, University of Western Australia, Perth, Australia (Drs Prince, Devine, Dick, Bruce, and Zhu and Ms Austin); Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Australia (Drs Prince, Dick, and Zhu); and School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Perth (Dr Devine).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

New Insights About Vitamin D and Cardiovascular Disease: A Narrative Review
McGreevy and Williams
ANN INTERN MED 2011;155:820-826.
ABSTRACT | FULL TEXT  

The 2011 Report on Dietary Reference Intake for Vitamin D: Where Do We Go From Here?
Aloia
J. Clin. Endocrinol. Metab. 2011;96:2987-2996.
ABSTRACT | FULL TEXT  

The Effect of Vitamin D on Falls: A Systematic Review and Meta-Analysis
Murad et al.
J. Clin. Endocrinol. Metab. 2011;96:2997-3006.
ABSTRACT | FULL TEXT  

Vitamin D intake and risk of cardiovascular disease in US men and women
Sun et al.
Am J Clin Nutr 2011;94:534-542.
ABSTRACT | FULL TEXT  

Vitamin D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
Elamin et al.
J. Clin. Endocrinol. Metab. 2011;96:1931-1942.
ABSTRACT | FULL TEXT  

10.1.6 Bone disease in older people
Prince
Oxford Textbook of Endocrinology and Diabetes 2011;2:med-9780199235292-chapter-med-9780199235292-chapter.
ABSTRACT | FULL TEXT  

Primary Care-Relevant Interventions to Prevent Falling in Older Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force
Michael et al.
ANN INTERN MED 2010;153:815-825.
ABSTRACT | FULL TEXT  

Parkinson's Disease: Mitochondrial Molecular Pathology, Inflammation, Statins, and Therapeutic Neuroprotective Nutrition
Kones
Nutr Clin Pract 2010;25:371-389.
ABSTRACT | FULL TEXT  

Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women: A Randomized Controlled Trial
Sanders et al.
JAMA 2010;303:1815-1822.
ABSTRACT | FULL TEXT  

Systematic Review: Vitamin D and Cardiometabolic Outcomes
Pittas et al.
ANN INTERN MED 2010;152:307-314.
ABSTRACT | FULL TEXT  

Systematic Review: Vitamin D and Calcium Supplementation in Prevention of Cardiovascular Events
Wang et al.
ANN INTERN MED 2010;152:315-323.
ABSTRACT | FULL TEXT  

How to assess the external validity of therapeutic trials: a conceptual approach
Dekkers et al.
Int J Epidemiol 2010;39:89-94.
ABSTRACT | FULL TEXT  

Vitamin D: An Evidence-Based Review
Kulie et al.
J Am Board Fam Med 2009;22:698-706.
ABSTRACT | FULL TEXT  

Existing and potentially novel functional markers of vitamin D status: a systematic review
Seamans and Cashman
Am J Clin Nutr 2009;89:1997S-2008S.
ABSTRACT | FULL TEXT